ABCC2 and cancer: A previous study has reported that efflux transporters' (P-gp, MRP1, and MRP2) expression of cancer cells is improved in a dose-dependent manner by genistein treatment for a long time [32], which would strengthen the first-pass metabolism of genistein (Figure 4).